Wednesday, August 10, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

BioWatch RFI – Autonomous Biodetection System

by Global Biodefense Staff
December 18, 2014
Biodefense Strategy

The Department of Homeland Security (DHS) has issued a new Request for Information (RFI) in support of the BioWatch program.

The goal of the Department of Homeland Security BioWatch program is to detect the presence of biological agents of concern in a timely manner and identify the target agents with a high degree of confidence.

BioWatch conducts near-continuous aerosol sample collection using dry filters to collect environmental particulates. Samples are manually retrieved and transported to a laboratory for analysis on a daily basis. The laboratory extracts particulate material from the filters and then prepares the material for analysis. The analysis begins with a screening of the sample, followed by a more in-depth confirmatory analysis if necessary.

Plans to automate this analysis process under BioWatch Gen 3 were put on hold earlier this year due to cost concerns.

This new RFI seeks technologies for autonomous biodetection system with capabilities to:

  • Identify multiple potential biological agents of concern simultaneously
  • Discriminate between target organisms and near-neighbors or background organisms
  • Demonstrate a high degree of sensitivity and specificity
  • Demonstrate a low rate of false positives and false negatives
  • Maximum six hour turnaround time (from sample collection thru analysis results transmission)
  • Preservation of sample viability to allow for potential further analysis
  • Adjustable collection cycle duration
  • Ability to archive time-resolved samples
  • Transmit data, results, and system status electronically to a remote operator control center
  • Ability to operate autonomously without human intervention for up to 2 weeks

The RFI will assist DHS in understanding the most current capabilities available to support possible future BioWatch solicitations.

Further details are available via Solicitation Number: HSHQDC-15-I-11105. The RFI response deadline is January 30, 2015.

This RFI is one of several being simultaneously released to assess the state of technologies that can improve the capabilities of the BioWatch Program, including in the areas of: Portable Biological Identifier Systems, Trigger/Detector Technologies, Aerosol Collection and Alternatives to PCR Detection.

Tags: BioterrorismBioWatchDHSHomeland SecurityRFI

Related Posts

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies
Biosurveillance

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
Influenza Research
Biodetection

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
The Bioethics and Biosecurity Aspects of Targeted Wastewater Surveillance
Biosurveillance

The Bioethics and Biosecurity Aspects of Targeted Wastewater Surveillance

June 9, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Load More

Latest News

Bacteria That Causes Melioidosis Confirmed in Environmental Samples in Mississippi Gulf Coast

Bacteria That Causes Melioidosis Confirmed in Environmental Samples in Mississippi Gulf Coast

July 27, 2022
Monkeypox Transmission: Virus Detected in Saliva, Bodily Fluids

Monkeypox Transmission: Virus Detected in Saliva, Bodily Fluids

July 17, 2022
Influenza Transmission Spikes During Social Gatherings

New Universal Flu Vaccine Offers Broad Protection Against Influenza A Virus Infections

July 17, 2022
Long COVID: National Academies’ Panel Examines Long-Term Health Effects of COVID-19

Long COVID: National Academies’ Panel Examines Long-Term Health Effects of COVID-19

July 17, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy